Abstract: TACN-based mono-and poly-nuclear metal complexes have found extensive use as biological mimics for understanding the structural and operational aspects of complex natural systems. Their coordination flexibility has also provided researchers access to a vast library of radiometal binding motifs that display excellent thermodynamic stability and kinetic inertness upon metal complexation. Synthetic modification on the TACN backbone has yielded ligands that can form metal complexes with coordination geometries well-suited for these applications. In particular, Leone Spiccia's research has played a significant role in accelerating the progress in these two fields. With a focus on providing an overview of his contributions to the biomimicry and radiopharmaceutical disciplines, this minireview uses relevant examples to put in perspective the utility of macrocyclic coordination chemistry for biological inorganic chemistry applications.
Introduction
Macrocyclic motifs, specifically metal complexes of azamacrocyclic ligands, present a powerful toolkit for tackling some key challenges in biological inorganic chemistry research. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] Critical for these applications is to exploit the basic principles of coordination chemistry, including Pearson's "hard and soft acids and bases" (HSAB) theory, coordination geometry preferences, and the thermodynamic stability and kinetic inertness of metal complexes. [1, 3, [5] [6] [7] 10, [12] [13] [15] [16] [17] 1,4,7-Triazacyclononane ( [9] aneN3 or TACN, Scheme 1) derivatives represent particularly attractive candidates in this regard since, compared to other tri-or tetradentate chelating ligands, their metal complexes can have much larger stability constants. [1, 18] Synthetic elaboration of TACN with a range of pendant groups has proven successful for controlling the coordination sphere and manipulating the metal complexation ability, as well as for introducing imaging and sensing capabilities. [8] [9] 11, 13, [17] [18] Research has generated structural and functional models for active sites of a number of metalloenzymes, [2] [3] 9, [11] [12] 18] which have deeply contributed to our understanding of different aspects of these natural systems. Similarly, a number of symmetrical and unsymmetrical TACN-derivatives integrated with chemically accessible side-arms have been generated for various medicinal chemistry applications. [7] [8] [9] [11] [12] 18] In this minireview, we bring together some of the examples that illustrate the utility of TACN-based scaffolds for developing effective chelators for radiopharmaceutical applications as well as bioinspired small molecule mimics. In particular, the aim of this review is to highlight some of the relevant structural and functional models prepared by the group of Leone Spiccia. As emphasised herein, this work has played an instrumental role in advancing our understanding of the coordinative interactions which are essential for strong metal ion-ligation in a complex biological setting, including the microenvironment of natural systems. 
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Structural models for metallobiosites
Synthetic considerations
Much of the work in designing TACN-based models for active sites of metalloenzymes has involved the development of synthetic routes to access suitably functionalised macrocycles as well as assemblies containing multiple linked macrocyclic units. "TACN-orthoamide" (Scheme 1), first reported by Atkins, [19] has proven to be a very versatile synthon in this regard. [20] It can be used to access ligands containing a variety of pendant groups, such as coordinating alcohol, amine, carboxylate and pyridyl groups, as well as non-coordinating aliphatic and aromatic groups (Scheme 1). [18, 21] TACNorthoamide is highly reactive towards a variety of electrophiles, [20] forming an amidinium salt, which can be easily hydrolysed in aqueous solution to yield a formyl derivative. This, in turn, can be reacted with a second electrophile and, following acidic hydrolysis of the resulting intermediate, with a third electrophile to form a trisubstituted, asymmetric TACN derivative, R1R2R3TACN. Other derivatives of type (R1)2R2TACN or (R1)2TACN can be produced by firstly hydrolysing TACNorthoamide to the formyl derivative and then repeating steps (d) to (f), or terminating at step (e). For the synthesis of multi-TACN ligand assemblies ( Figure  1) , [18] the orthoamide is first reacted with various bis/tris/tetrakiselectrophiles to generate poly-amidinium salts; these are then hydrolysed to yield the final products. There is also a possibility to introduce additional substituents onto the linked TACN rings, both following the initial aqueous hydrolysis of the polyamidinium salts, and/or after the acidic hydrolysis step. Because of its simplicity and versatility, the TACN-orthoamide approach to substituted and/or polymacrocylic TACN systems has largely superseded older routes based on the use of tosylate precursors or diprotected TACN derivatives. [18, [21] [22] [23] Figure 1 . Examples of multi-TACN ligands developed by Spiccia and coworkers. [18] Metallobiosite mimicry TACN has been extensively used to create viable models of copper protein active sites. [2, 10, 12, 18] For example, Cu-TACN complexes have been employed in the development of simplified models for the mono-, di-or trinuclear Cu-ligating environment found in catechol oxidase, cytochrome c oxidase, nitrite reductase, galactose oxidase, laccase, ceruloplasmin, and dicopper dismutase. [2, [8] [9] [11] [12] 18, 24] Examination of the X-ray structures of a large number of copper proteins has revealed that, in most cases, the Cu(II) centre resides in a square pyramidal (SP) coordination environment generated from the histidine residues present within the protein and the aqua ligands. [8] [9] 24] Structural studies on bis(TACN)-based synthetic multinuclear Cu(II) complexes (e.g., Cu(II)-1-8) also established a similar SP geometry about the Cu(II) centre. [18] The stabilisation of this geometry over a trigonal pyramidal one lends support to the contention that the TACN prefers to occupy one of the four smaller faces of an axially elongated square pyramid than the larger face of a trigonal pyramid. [1] Systematic variation of the intramolecular Cu…Cu distance in these binuclear models also showed that the electronic interaction between the Cu(II) centres diminishes with increasing separation. The complexes studied range from ones that display moderate antiferromagnetic coupling, e.g., Cu(II)2-12 (J = -86 cm -1 ), [25] featuring an endogenous alkoxo-bridged pair of Cu(II) centres separated by ~3.6 Å, through to ones exhibiting strong antiferromagnetic interaction between the Cu(II) centres, e.g., Cu(II)2-13 (J ≈ -150 10.1002/cplu.201800103
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ChemPlusChem cm -1 ), [26] an oxalato-bridged binuclear Cu(II) complex with a very large Cu...Cu separation (~5.2 Å) ( Figure 2 ). , reported by Meyer and co-workers. [8] This particular complex illustrates one of the ways in which the copper proteins may activate dioxygen. [2, 8] Figure 3. Examples of multinuclear Cu(II) complexes applied in biomimicry. [8, 16, [27] [28] Cu(I)-TACN complexes have also shown ability to catalyse dioxygen reduction to H2O, akin to cytochrome c oxidase. [2, 16, 27] For instance, heterobimetallic Cu(I)/M(II) (M=Co, Fe) complexes, -reduction of O2 to H2O at physiological pH, with little to no peroxide release ( Figure  3 ). [16, 27] Imidazolate-bridged Cu(II)3-17 ( Figure 3 ) is another complex that structurally mimics the trinuclear unit of the natural ascorbate oxidase (AO). [28] X-ray structure of this Cu3 adduct revealed a Cu…Cu separation of 5.92 Å. In addition, the complex exhibits spin-frustration due to the three Cu(II) centres being equivalent to each other. In comparison to the intermetallic separations (3.4, 3.9, and 4.0 Å) in the AO active site, the metal centres in Cu(II)3-17 lie further apart because the Cu(II)-TACN units are interconnected via imidazolate instead of a μ3-X coordinating ligand. [28] A unique trimetallic cluster modelling the active site of phosphate-metabolising enzymes was reported by Lippard and co-workers (Cu(II)3-18, Figure 3) . [29] Reacting 18, a tripodal tris(TACN) ligand, with CuCl2 in the presence of HPO4 2- yielded a phosphate-bridged tricopper assembly that not only remained intact upon dissolution, but also demonstrated efficient phosphoester hydrolysis. [29] Nickel is present at the active sites of enzymes such as carbon monoxide dehydrogenase, urease and [Ni-Fe]-hydrogenase, while manganese-containing active sites are present in biological systems such as photosystem II, ribonucleotide reductase, superoxide dismutase and Mn catalases. [6, [9] [10] [30] [31] [32] Likewise, Zn(II) is present at the active sites of enzymes responsible for catalysing hydration reactions, RNA polymerization or phosphoryl transfer reactions, and μ-oxo/hydroxo-diiron motifs are present in non-haeme, non-sulfur iron proteins carrying out specific functions such as dioxygen transport and storage (haemerythrin), alkane hydroxylation (methane monooxygenase), and phosphate ester hydrolysis (purple acid phosphatases). [6, 10, 14, [33] [34] [35] This has sparked interest in the development of TACN-based (polynuclear) Mn(II), Ni(II), Zn(II) and Fe(III) complexes as synthetic mimics. For example, pentadentate TACN rings when linked by an endogenous 2-propanol-based alkoxo bridge produced a binuclear Zn(II) complex, Zn(II)2-8 ( Figure 4) with Zn...Zn separation very similar to the dizinc active site of alkaline phosphatase (3.94 Å). [22] Interestingly, the M...M distances in related binuclear Zn(II)-and Ni(II)-TACN complexes devoid of the 2-pyridyl pendant were significantly shorter (3.68 and 3.81 Å, respectively). [25, 36] 
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Electrochemical measurements on binuclear Mn(II) and Ni(II) complexes of bis(pentadentate) TACN (e.g., 1-8 in Figure 1 ) have established that, in general, the oxidation potential for the individual metal centres decreases with an increase in the M...M separation. [36] [37] [38] [39] These distances were found to be shorter in the Mn(II) complexes than those in the corresponding Ni(II) complexes, viz. 8.279(3) Å vs. 9.563(4) Å for the butyl-bridged complexes, Mn(II)2-3 and Ni(II)2-3, respectively. [39] [40] This may have its origin in the differing coordination geometries, i.e., distorted octahedral for the Ni(II) centres, vs. intermediate between octahedral and trigonal prismatic for the Mn(II) centres ( Figure 5 ). [39] [40] An oxo-bridged diiron(III) complex, Fe(III)2-19 ( Figure 6 ), incorporating a bridging carboxylate, was proposed to be a good model for haemerythrin and ribonucleotide reductase B2, as the Fe...Fe separation of 3.21 Å matched closely those for the diiron(III) sites in these metalloproteins ( Figure 6 ). [41] Additionally, several other bioinspired models for active bimetallic sites in metalloproteins have also been developed (representative examples are shown in Figure 7) . [2, 5, [8] [9] 16, 18, [42] [43] [44] [45] Taken together, the above examples clearly demonstrate the versatility of TACNbased ligands in the construction of simple bimetallic as well as higher nuclearity systems that are able to broadly mimic the structural and, in some cases, spectral and magnetic features of the active sites of several important metalloenzymes. Other examples of non-copper containing bimetallic metallobiosite models. [42] [43] [44] [45] 
Radiopharmaceutical Chelates
TACN-based radiocopper chelators
A variety of TACN motifs bearing pendant amine, amide, sulfhydryl, carboxyl, phosphinate, phosphonate, imidazolyl, thiazolyl, pyridinyl and pyrazolyl groups have been investigated as azamacrocyclic chelators for radiometals (Figure 8 ). [46] [47] [48] [49] [50] [51] [52] [53] [54] Examples of such radiometals include the imaging-related gamma-and positron-emitting radioisotopes 67 Ga, 99m Tc,
111
In, 177 Lu for single photon emission computed tomography (SPECT), 68 Ga, 64 Cu, 44 Sc, 86 Y for positron emission tomography (PET) as well as particle-emitting (beta and alpha) 47 Sc, 90 Y, 177 Lu, 212 Pb and 212/213 Bi for therapeutic applications. Of these, the positronemitting 64 Cu radioisotope has garnered specific interest due to its favourable decay characteristics (t1/2 = 12.7 h; β + max = 0.655 MeV; β -max = 0.573 MeV) that allow simultaneous PET imaging and radiotherapy. [55] Here, in addition to the emitted β -particles,
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Auger and conversion electrons can be exploited for enhancing the therapeutic efficacy. [56] The β --emitting 67 Cu (β -max = 0.577 MeV, t1/2 = 62 h) is another highly attractive Cu radioisotope useful for therapeutic applications.
Metal-based radiopharmaceutical applications require chemically robust and radiolytically stable ligands, which can form radiometal complexes of high thermodynamic stability and kinetic inertness. For TACN derivatives, their radiocopper complexation ability is greatly influenced by the number and type of substituents on the macrocyclic ring. The formed metal complexes show a broad variability in their complexing properties, and present Cu(II) coordination chemistry similar to their non-radioactive counterpart (Table 1 and Figure 9 ). The pristine tridentate TACN ligand forms a highly stable Cu(II) complex (log KCu(II)-TACN = 15.52), with a 1:1 Cu(II):TACN stoichiometry. When pyridylmethyl pendants are introduced onto the TACN backbone (e.g., 24-26 in Figure 8 ), the stability of Cu(II) complex is further increased due to the pendant arm coordination to the metal centre. For the complex of the trisubstituted TACN derivative, Cu(II)-25, formation constant (log KCu(II)-25) is 27.4, which is similar to that for Cu(II)-cyclam and Cu(II)-cross-bridged cyclam complexes (log K ≈ 27.1). [57] [58] A pyridylmethyl side-arm when replaced with carboxylate functionality, as in 26, provides site for further attachment of vector molecules for pharmaceutical targeting. Complex Cu(II)-26 (log KCu(II)-26 > 25), in particular, exhibits very high in vivo stability after 64 Cu-radiolabelling. [59] However, any further substitution of pyridylmethyl pendant leads to a decrease in stability of the complexes. [60] [61] Of the picolinate-bearing TACN ligands, the Cu(II) complex of the monopicolinate derivative, Cu(II)-34, has the highest stability (log KCu(II)-34 = 20.96), also showing efficient 64 Culabelling. [61] However, the stability of Cu(II) complexes decreases as additional picolinate arms are attached to the macrocycle. Similarly, the TACN-triphosphinate derivatives 28 and 29 ( Figure  8 ) also yield 64 Cu(II) complexes with moderate stability 64 and sufficient kinetic inertness to allow PET imaging at early time points. [62] NOTA derivatives are other well-studied TACN systems for radiolabelling. Their commercial availability, along with the ability to form very stable and kinetically inert 64 Curadiolabelled complexes under mild conditions, makes them almost ideal chelators for radiocopper. Quite recently, another promising class of TACN-based chelators featuring the imidazolyl (30 and 31) and the thiazolyl pendant (32 and 33) has been developed (Figure 8) . [63] [64] These derivatives show fast and efficient radiolabelling (radiochemical yield > 95% within 30 min) with 64 Cu(II), even under mild conditions (pH 7.4, r.t). Interestingly, these complexes exhibit kinetic inertness comparable to the NOTA complex Cu(II)-27, which is more prone to demetalation/transchelation in the presence of an excess of the non-radioactive Cu(II), and under highly acidic conditions. In particular, Cu(II)-33 shows an exceptionally long half-life of ~55 h. Notably, PET imaging studies in mice revealed a higher retention of 64 Cu(II)-30-33 in the kidneys and liver compared with 64 Cu(II)-NOTA/DOTA. 
Bifunctional chelating agents (BFCAs)
TACN-based bifunctional chelating agents (BFCAs) have also been used for indirect radiolabelling of biomolecules, rendering them suitable for imaging and therapy. BFCAs serve the dual purpose of binding to the radionuclide efficiently and forming a highly stable complex, as well as of providing a functionality and/or site for attaching biological vectors. The linker connecting the biomolecule to the BFCA backbone helps to tune the lipophilicity, overall charge and aqueous solubility of the radiolabelled conjugate, and thus the overall biodistribution and pharmacokinetic properties. Figure 10 summarises the BFCAs used for copper radioisotopes. The Cu(II) complex of bromo-functionalised NOTA derivative, Cu(II)-41, has been used for antibody labelling. [65] BFCAs possessing amino or carboxyl groups (e.g., 42, 46-48, 64 in Figure 10 ) have been developed for coupling to the biomolecules via peptide coupling protocols. [66] [67] [68] [69] [70] One should note here that this strategy can only be applied provided that the stability of the radiometal complex is not harmed and steric restrictions do not occur. For example, maleimide-functionalisation in 44, 49 and 63 enables attachment to biomolecules (e.g., peptide, antibodies, oligonucleotides) via a 10.1002/cplu.201800103
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ChemPlusChem This article is protected by copyright. All rights reserved. stable thioether linkage with sulfhydryl groups. [71] [72] [73] [74] [75] [76] Similarly, isothiocyanate-functionalised TACN derivatives 45, 50-54, and 65 can be linked to amine-terminated biomolecules via very stable thiourea bonds. [76] [77] [78] [79] [80] Over the last decade, clickable versions of BFCAs have also been used for tagging different biomolecules and nanoparticles to allow PET imaging using 64 Cu. [81] [82] [83] [84] Examples of these include ligands 55, [85] , 56 and 60 [86] for rapid conjugation to specific peptides via Cu(I)-catalysed click reaction, and strained cyclooctyne featuring 57-59 [82] [83] [84] for copper-free attachment to azide-functionalised peptides, proteins and nanoparticles. Also, tetrazine-bearing NOTA derivatives 61 and 62 have been employed for linking the transcyclooctene-functionalised antibodies using inverse-demand Diels-Alder reaction. [87] [88] [89] 27.4 [60] 21.63 [90] 13.43 [91] 16.85 [92] 20.77 [64] 20.96 [60] 18.32 [60] 16.21 [60] The BFCA can be radiolabelled before or after its attachment to the biomolecule, using well-established protocols (Figure 11) . However, the labelling should be rapid, efficient, and devoid of demanding purification steps. Moreover, to achieve exact quantitative biodistribution and pharmacokinetic data, it should be ensured that the radioisotope binds to the BFCA strongly as any radiometal leakage in living systems will lead to inaccurate determinations. [63, [93] [94] Owing to the favourable binding affinity of NOTA (27) for copper radioisotopes, in vivo studies have mostly been performed with 64 Cu(II) complexes of NOTA-attached biomolecules and, derivatives thereof. For example, 64 Cu(II)-27 was coupled to a bombesin (BBN) tetradecapeptide to target the gastrin-releasing peptide receptor (GRPR). [95] Similarly, 64 Cu(II)-27-ML was developed for PACE4-targeted prostate cancer detection, [96] 64 Cu(II)-27-KCCYSL for recognizing epidermal growth factor receptor (EGFR) rich breast carcinoma, [97] 64 Cu(II)-27-α-MSH for melanoma imaging [98] and 64 Cu(II)-27-HsTX1 for targeting the potassium channel. [99] Moreover, seeking dual targeting, 64 Cu(II)-47 derivatives equipped with peptides that target prostate-specific membrane antigen (PSMA) and GRPRrich tumours have also been developed. [100] Another NOTA 10.1002/cplu.201800103
derivative, 61 ( Figure 10 ), has been used for 64 Cu-radiolabeling of A33 antibody to evaluate a pre-targeting approach.
As Cu(II) complexes of 2-pyridylmethyl substituted TACN (24, Figure 9 ) show excellent in vivo stability, the 64 Cu(II)-24-BBN conjugate has been used to radioimage human prostate PC3 tumours, showing similar performance as the reported analogues. [101] Recently, TACN derivatives have also been grafted on different nanomaterials [67, 76, [102] [103] to develop nanoscale bioimaging platforms. For example, ligands 63-65 have been used to introduce Cu(II) binding motifs on dendritic polyglycerols (dPGs)-based bioactive and iron oxide nanoparticle-based imaging agents. [67, 76, [102] [103] 
Summary and Outlook
This minireview sheds light on the use of TACN-based molecular scaffolds for generating simplified mono-and polynuclear models for active sites of metalloenzymes, as well as chelators for metal-based radiopharmaceuticals. Tridentate coordination of TACN to metal ions leaves two or three vacant sites in the coordination sphere that can be exploited for mimicking the desired structural or functional aspects of the metal ion-binding biosite environment. Similarly, by applying principles of coordination chemistry, it is possible to tune the affinity of TACN-based ligands for radiometal ligation, as well as their availability for subsequent biomolecular functionalisation. Collectively, the examples presented herein provide a picture of how different substituents influence the coordination mode, functional properties, reactivity as well as in vivo stability of various TACN constructs and their transition metal complexes. With regards to the use of radiocopper labelled TACN derivatives for therapeutic applications, progress has been relatively slow due to the fact that there is currently a shortage of therapy-relevant 67 Cu radioisotope. However, with increasing availability of cyclotrons that can produce high-energy protons, and active engineering of new TACN motifs for 67 Cu binding, this situation is also most likely to change in the near future.
